BioCentury
ARTICLE | Clinical News

Human embryonic germ cells regulatory update

December 24, 2001 8:00 AM UTC

Johns Hopkins University (Baltimore, Md.) received U.S. Patent No. 6,331,406 covering the use of human embryonic germ cells in drug screening assays. GERN is the exclusive licensee of the patent. ...